Verified stock metrics
Inhibikase Therapeutics Key Stock Metrics
Direct answer
Inhibikase Therapeutics has 6 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked October 22, 2026.
Get free Inhibikase Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $227.44M
- Price-to-book ratio
- 1.86x
- Return on equity
- -51.96%
- Dividend yield
- 0%
- 52-week price range
- $1.33 to $2.61
- Profit margin
- 0%
Explore related company data
View Inhibikase Therapeutics's market capitalizationView Inhibikase Therapeutics's price-to-book ratioView Inhibikase Therapeutics's return on equityView Inhibikase Therapeutics's dividend yieldView Inhibikase Therapeutics's 52-week price rangeView Inhibikase Therapeutics's profit marginReturn to Inhibikase Therapeutics profile